What's on the web on your pursuit, hobbies, interests and worries

GraftVersusHostDisease news

Alexion's ALXN1007 Earns Orphan Drug Status (ALXN)

Investopedia - Oct 20, 2016
With its orphan drug status, Alexion's ALXN1007 is eligible for certain benefits and incentives, including a period of marketing exclusivity in the US once it is approved for Graft-Versus-Host Disease (GVHD). (For more, see Alexion Gets U.K. Approval ...

Global Graft Versus Host Disease (GVHD) Pipeline Review 2016

Business Wire (press release) - Oct 21, 2016
'Graft Versus Host Disease (GVHD) - Pipeline Review, H2 2016' outlays comprehensive information on the therapeutics under development for Graft Versus Host Disease (GVHD), complete with analysis by stage of development, drug target, mechanism of ...

Japan Graft Versus Host Disease (GVHD) Market Insights, Epidemiology and Market Forecasts, 2023

Business Wire (press release) - Oct 17, 2016
Japan Graft versus Host Disease (GVHD) - Market Insights, Epidemiology and Market Forecasts, 2023 report provides an overview of the disease and global historical and forecasted epidemiological data for the diagnosed incident cases of Hematopoietic ...

Graft Versus Host Disease - premium items on eBay

NEW Chronic Graft Versus Host Disease: Interdisciplinary Management by Georgia B




Chronic Graft Versus Host Disease : Interdisciplinary Management (2009,...


>> Go to all great Graft Versus Host Disease deals on eBay

Graft Versus Host Disease books

Chronic Graft Versus Host Disease: Interdisciplinary Management

Chronic graft versus host disease (GVHD) is the most common complication of allogenic bone marrow transplantation. Because of the protracted clinical course of chronic GVHD, transplant centers and hematology/oncology offices are inadequately equipped to manage these immuno-incompetent patients with a multi-system disorder. Practitioners need to be able to recognize and effectively manage chronic GVHD as a late effect of more than half of allogenic transplantations. The text is oriented for the clinician, with chapters covering staging, organ site and system-specific manifestations, treatment options, and supportive care.
>> More info on Amazon

Graft vs. Host Disease, Third Edition

With detailed contributions from more than 40 leading authorities on the topic, this Third Edition comprehensively explores the immunobiology, pathophysiology, and clinical manifestations of graft-versus-host disease (GVHD)-offering sections revealing the most up-to-date research on immune activation and dysregulation, the pathophysiology of target organ damage, and GVHD prevention and treatment.
>> More info on Amazon

Clinical and Diagnostic Pathology of Graft-versus-Host Disease

by: Berno Heymer
While comprehensive descriptions of the various aspects of Graft-versus-Host Disease (GvHd) have already been published, to date there is no monograph on the clinical and diagnostic pathology of this life-threatening disease. This book fills this gap and serves as a reliable guide to the histomorphologic diagnosis of GvHd. It contains a concise description of: the clinical pathology of GvHd; the applicability and limits of immunohistologic methods in the diagnosis of this disease; an instructive guide to the histological diagnosis; and differential diagnostic problems and potential diagnostic pitfalls.
>> More info on Amazon

Immunobiology of Graft Versus Host Disease: Introduction of new mouse model of BMT and GVHD based on chemotherapy conditioning

by: Behnam Sadeghi
Stem cell transplantation (SCT) is a curative treatment for many malignant diseases, metabolic and genetic disorders.Several complications limit the expanded application of this method. Graft versus host disease (GVHD) is one of the most serious complications related to SCT. During the last decades, sustained efforts have been made to conquer GVHD. Animal models play an important role in understanding the pathophysiology of GVHD and subsequently successful therapeutic strategy. The present book aptly summarizes updated knowledge about the pathogenesis and immunobiology of GVHD in a simple language and also presents a new mouse model of GVHD based on chemotherapy conditioning.
>> More info on Amazon

>> Go to all Graft Versus Host Disease books

Graft Versus Host Disease pictures on the web

>> Show

Graft Versus Host Disease videos

Graft-Versus-Host Disease: Diagnostic and Therapeutic Advances

2013 Clinical Education Conference Daniel R Couriel, MD, University of Michigan.

Dr. Marco Mielcarek Explains Graft-Versus-Host Disease (GVHD) and Shares Some Promising Treatments

Graft-versus-host disease (GVHD) is a common side-effect from bone marrow transplantation when a person receives donor cells (allogeneic transplant). GVHD ...

Graft-Versus-Host Disease

Dr. Sergio Giralt talks about the role of the immune response in bone marrow transplantation.

Graft versus Host Disease (2/3)

An educational video for healthcare professionals.

Graft versus Host Disease (1/3)

An educational video for healthcare professionals.